Canadian Silver Developer Plans to Ramp-Up Production at Mexico Property in Early 2022
Source: Streetwise Reports  (11/10/21)
MAG Silver Corp. is now engaged in the pre-commissioning phases of its new 4,000 tpd mill at the Juanicipio JV Project in Fresnillo, Mexico that when finished is expected to provide the company with 9,000,000 ounces of pre-payable silver production each year. More >

Explorer's Mexico JV On Pace to Become World's Largest Primary Silver Mine
Source: Streetwise Reports  (11/10/21)
MAG Silver Corp.'s Fresnillo joint venture project is on track heading towards annual production of 27 Moz Ag eq. Stifel Canada has issued a "Buy" rating for the company and recently added the company to its list of Top Picks for Q4/21. More >

Iberia Belt Explorer's Prospects for Positive Outcomes in Court Cases Remain Positive
Source: Streetwise Reports  (11/10/21)
Emerita Resources Corp. issued an update regarding the status of two ongoing independent court cases in Spain and its prospects for winning the tender for the Aznalcóllar project. Research Capital Corp. commented in a research note that it believes the company has at least an 80% probability of being successful in the cases and is maintaining a "Speculative Buy" rating for the company. More >

Microbiome Therapeutics Co.'s Shares Rise on Q3 Earnings & Partnership With Swiss Manufacturing Firm
Source: Streetwise Reports  (11/10/21)
Shares of Seres Therapeutics Inc. traded 20% higher after the company reported Q3/21 financial results and announced it is partnering with Bacthera in Switzerland to manufacture medicine for use in c.Diff treatment. More >

Brucejack Mine Operator Agrees to CA$3.5 Billion Buyout Bid From Newcrest Mining
Source: Streetwise Reports  (11/9/21)
Shares of Pretium Resources Inc. traded 17% higher after the company reported it entered into a binding agreement to be acquired by Newcrest Mining Ltd. of Australia for CA$18.50 in cash and shares. The transaction is valued at CA$3.5 billion and allows shareholders the choice of receiving all cash, shares in Newcrest or a 50% split of each. More >

US DEA OKs Use of Psychedelics by This Mental Health Network
Source: Streetwise Reports  (11/9/21)
Clinics that deliver novel psychiatric treatment and host clinical trials of psychedelic medicine have positioned Novamind for breakthroughs in mental health treatment. More >

Precommissioning Revenues to 'Offset Initial Capital Requirements' for MAG Silver
Source: Streetwise Reports  (11/9/21)
This cost mitigation will derisk Juanicipio plant commissioning and ramp-up expected by year-end 2021, noted an H.C. Wainwright & Co. report. More >

This Yukon Explorer Is a 'Strong Buy'
Source: Clive Maund for Streetwise Reports  (11/9/21)
Sector expert Clive Maund says that White Gold Corp.'s fundamentals 'look impressive' and that 'fresh purchases are in order.' More >

New Mineralized Target at Yukon Project Could Boost Resource to 2,000,000 Ounces, Entice Buyer
Source: Streetwise Reports  (11/8/21)
"The fact that White Gold's drilling hit fairly wide zones of high grade at shallow depth bodes well for both the mineral endowment and mineability of the emerging zone," noted a Stifel report. More >

MAG Silver to Hit Major Catalyst by Year-End With Juanicipio Commissioning
Source: Streetwise Reports  (11/8/21)
All that needs to be done beforehand is connecting to the Mexico power grid then no-load and water testing, noted a Cormark report. More >

Key Data Readouts Expected in 2022 for Developer of Cancer Immunotherapies
Source: Streetwise Reports  (11/8/21)
Results expected are for trials of Jounce Therapeutics' two lead product candidates, vopratelimab and pimivalimab, both monoclonal antibodies, noted a ROTH Capital Partners report. More >

Programmed T Cell Therapies Co. Receives $250M Investment From Blackstone to Advance Adult Leukemia Treatment
Source: Streetwise Reports  (11/8/21)
Autolus Therapeutics Plc. shares traded 28% higher after the company reported that Blackstone Life Sciences is investing up to $250 million in the firm to develop obe-cel in treatment of adult Acute Lymphoblastic Leukemia and advance its broader targeted T- Cell technology platform. More >

Standard Lithium Announces Positive PEA At Southwest Arkansas Lithium Project
Source: The Critical Investor for Streetwise Reports  (11/5/21)
The Critical Investor discusses the status of the projects of Standard Lithium, one of the major lithium developers in the Americas, and lithium product pricing in this quick update. More >

Soaring Fertilizer Prices Threaten to Diminish Crop Yields, Send Futures Even Higher
Source: McAlinden Research for Streetwise Reports  (11/5/21)
McAlinden Research Partners explains that while climate related disruptions have become standard in the agricultural industry, a new catalyst has recently emerged that could keep futures contracts climbing next year. More >

Innovative Small Cap Extracting Platinum and Palladium Using Cleantech
Source: Lara Smith for Streetwise Reports  (11/5/21)
As the world adopts Cleantech as a means to curb environmental pollution, U.S.-based Mineworx Technologies Ltd. (MWX:TSX.V) has found a technological replacement for the traditional mining of precious metals. Mineworx uses its unique cleantech to economically and cleanly extract platinum and palladium from spent diesel catalysts. More >

Specialty Pharma Co. Increases Revenues by 22% in Q3; Raises FY Sales and Earnings Forecast
Source: Streetwise Reports  (11/5/21)
Shares of brand, generic and injectable drug maker Endo International traded 25% higher after the company reported Q3/21 financial results and raised its FY/21 revenue and EPS guidance. More >

Thinking & Looking Outside the Box: 10 Investment Ideas
Source: Chris Temple for Streetwise Reports  (11/5/21)
Chris Temple of The National Investor profiles 10 companies in a variety of sectors on his recommended list. "I very much am of the view that a great many resource-oriented stories and the best companies have incredible futures ahead of them," he writes. More >

No ‘Better Opportunity’ Than This Gold Explorer
Source: Streetwise Reports  (11/4/21)
Has the Klondike Gold Rush 2.0 quietly begun? Modern technologies and a century of accumulated know-how are catalyzing new discoveries in the Yukon, and one company at the center of the action is White Gold Corp. CEO David D'Onofrio was bullish in an interview with Streetwise Reports: "From a risk/reward perspective, I can't think of a better opportunity." More >

Meridian Mining Drills Visible Gold, Increases Strike to Over 900m at Cabaçal Northwest Extension
Source: The Critical Investor for Streetwise Reports  (11/4/21)
As Meridian Mining has been pretty busy at its Cabaçal VMS Copper-Gold Project in Brazil lately, raising an oversubscribed C$10.38M, drilling world class gold intercepts (8m @ 71.3g/t Au), other visible gold and long copper intercepts, defining new targets and gold structures, and is increasing strike length of mineralized zones, the Critical Investor catches up with management to discuss ongoing developments in a rather extensive update. More >

Robotic Surgical Device Maker's Shares Maneuver Higher on Q3 Earnings
Source: Streetwise Reports  (11/4/21)
Shares of robotic performance-guided surgery device maker Asensus Surgical Inc. traded 21% higher after the company reported Q3/21 financial results that included a 215% increase in YoY revenue. More >

Gold Mining on Verge of 'Age of Discovery' Like What Occurred Between 1980 & 1997
Source: Quinton Hennigh for Streetwise Reports  (11/3/21)
In an Oct. 8, 2021, broadcast, Crescat Capital Geologic and Technical Director, Dr. Quinton Hennigh, discussed the cycles in the gold market since the 1970s and posited that the U.S. is on the verge of a bull run in the gold price and another "age of discovery." More >

Surgery Center Operator Posts 23% Increase YTD Revenue and Raises FY21 Adjusted EBITDA Estimates
Source: Streetwise Reports  (11/3/21)
Surgery Partners shares traded 18% higher after the company reported Q3/21 financial results that included a 12.7% increase in YoY revenue and a 6.2% increase in the number of same-facility procedures performed. More >

Precision Medicine Co.'s ASM Treatment Drug Gaining Rapid Market Adoption
Source: Streetwise Reports  (11/3/21)
Wedbush Securities Inc. advised that global precision therapy company Blueprint Medicines Corp.'s therapeutic AYVAKIT is gaining traction in patients diagnosed with advanced systemic mastocytosis and gastrointestinal stromal tumors. Wedbush reiterated its Outperform rating for the company and raised its 12-month price target by $4.00 to $136.00 per share. More >

Gold Explorer in Ontario Recommended as a Buy
Source: Chris Temple for Streetwise Reports  (11/3/21)
Chris Temple of The National Investor explains why he has put E2Gold on his buy list and why he believes E2Gold has the potential to multiply its resource base, and geologic expert Dr. Quentin Hennigh agrees. In a statement made today, Hennigh told Streetwise why E2 is a buying opportunity for long-term investors right now.
More >

Psychedelic Drug Trials Accelerate as Decriminalization Spreads, Investment Expands
Source: McAlinden Research for Streetwise Reports  (11/3/21)
McAlinden Research Partners estimates it may be only a matter of time before psychedelics become part of a biotech boom. More >